“The data available are insufficient to assess any potential benefit or harm from polyunsaturated fatty acids (PUFA) supplementation,” according to researchers from the Istituto Nazionale Neurologico Carlo Besta in Milan, Italy.
Here’s what they found after reviewing the available research. Continue reading Lack of benefit of fatty acids in multiple sclerosis
Respiratory muscle strengthening programs are either inspiratory or expiratory and typically use handheld devices.
Dr. Christine Sapienza from the University of Florida in Gainesville tells us if it makes a difference. Continue reading Respiratory muscle strength training
GW Pharmaceuticals has announced that its major study of Sativex in 339 patients with central neuropathic pain due to multiple sclerosis (MS) failed to provide adequate pain relieve in patients who had failed conventional therapy previously. Continue reading Cannabis drug fails in neuropathic pain due to MS
In their article published in InsideMS, Dr. Allen Bowling and Tom Stewart caution, “It’s not clear if omega-3 fatty acids really improve multiple sclerosis (MS).”
However, there is a scientific rationale for this supplement and some hints of effectiveness.
Continue reading The National Multiple Sclerosis Society reviews omega-3 fatty acids
In preparation for the upcoming weight management conferences in Europe, here is what we know about the value of herbals as an aid to weight loss.
Continue reading Herbal supplements for weight loss: What works, what doesn’t
Hillary Freeman has multiple sclerosis (MS). She says, that within weeks of “regularly incorporating portions of salmon, mackerel, and sardines into my meal plans, the tingling and numbness I experienced on a daily basis subsided.”
Now, research on omega-3 fatty acids (containing eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) conducted at Oregon Health & Science University in Portland and presented during the American Association of Naturopathic Physicians annual meeting appears to provide a rationale for her experience. Continue reading Growing support for omega-3 benefits in multiple sclerosis
A spray has been developed from the major components of marijuana (cannabis), including tetrahydrocannabinol (THC) and cannabidiol (CBD) in alcohol. The formulation is sprayed under the tongue or in the cheek to relieve pain in multiple sclerosis.
This small study examined effects on the mucus membrane of the mouth. Continue reading Safety report on cannabis oral spray
GW Pharmaceuticals was able to prove that Sativex, their marijuana oral spray product, was safe and reliably contained sufficient tetrahydrocannabinol. But proof of effectiveness was lacking, in the view of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) Continue reading Insufficient proof of efficacy for marijuana spray to permit sale in the UK
Here are highlights from the American Academy of Pain Medicine 23rd Annual Meeting
Sativex Oromucosal Spray Continue reading Update on cannabinoids to treat pain
The Oncology Nursing Society has posted a table that summarizes CAM studies on the treatment of nausea and vomiting in cancer patients. The studies were published between 1988 and 2005.
Here’s a summary of their findings.
Continue reading Evaluating CAM to treat nausea and vomiting in cancer patients
“The main voices in favor of DHEA as a miracle drug are those who are selling it or who make a good living selling books or programs advocating ‘natural cures’.” That’s the conclusion from the Skeptics Dictionary. But look for yourself, and you will agree.
Here is another reason to be skeptical of DHEA [dehydroepiandrosterone].
When tai chi is adapted to the needs of patients with multiple sclerosis (MS), the slow, gentle movements help improve muscle tone.